In the case Rees v. Hoffman-LaRoche, Inc., a New Jersey jury awarded the plaintiff $1,587,928 in what is the ninth straight Accutane trial verdict in favor of plaintiffs. The jury found that the drug could cause ulcerative colitis and that Hoffman-La Roche, its manufacturer, failed to adequately warn of this risk. Trial ran from January 27 to March 10, and the jury rendered its verdict in less than a day.
Accutane was a drug for treatment of ...
continue reading...